← FDA Drug Approvals (Drugs@FDA)

BENDAMUSTINE HYDROCHLORIDE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MEITHEAL · Approved 2023-06-05

Drug application

FDA Application #

ANDA211001

Application type

Abbreviated New Drug Application (Generic)

Brand name

BENDAMUSTINE HYDROCHLORIDE

Generic name

BENDAMUSTINE HCL

Active ingredients

BENDAMUSTINE HYDROCHLORIDE

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MEITHEAL

Manufacturer

Meitheal Pharmaceuticals Inc.

First approval

2023-06-05

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown